Plain-English translation of NCT07391345 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing three different ways to treat early-stage voice box cancer: laser surgery, radiation therapy, and a newer type of radiation guided by MRI scans. Researchers want to find out which approach gives patients the best chance of staying cancer-free while keeping their voice and ability to swallow as healthy as possible.
Early-stage voice box cancer can be treated in several ways, but doctors aren't sure which method is best for most patients. This trial will help determine which approach offers the best balance of curing the cancer and preserving normal voice and swallowing function.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive one of three treatments: laser surgery to remove the cancer, standard radiation therapy, or newer MRI-guided radiation therapy. You will have medical visits and tests to monitor how well your treatment is working and to check for any side effects. The study will also assess how well you can speak, swallow, and breathe after treatment.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Lithuania
Sponsor
Viktoras Rudzianskas
Enrollment target
~105 participants
Started
September 2024
Primary completion
September 2029
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Viktoras Rudzianskas
Viktoras Rudzianskas
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.